PlainRecalls
FDA Devices Low Class III Terminated

PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)

Reported: September 5, 2012 Initiated: August 2, 2012 #Z-2285-2012

Product Description

PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)

Reason for Recall

Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.

Details

Recalling Firm
Phadia US Inc
Units Affected
837 kits (96 assays per kit), total of 80,352 individual assays
Distribution
USA Nationwide.
Location
Portage, MI

Frequently Asked Questions

What product was recalled?
PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies). Recalled by Phadia US Inc. Units affected: 837 kits (96 assays per kit), total of 80,352 individual assays.
Why was this product recalled?
Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.
Which agency issued this recall?
This recall was issued by the FDA Devices on September 5, 2012. Severity: Low. Recall number: Z-2285-2012.